Lab to Lives

Pharma Wants A Cupcake But Gets Ingredients w/ Dr. Isabelle Widmer

Send us Fan Mail Pharma doesn’t usually fail because the science is too hard. It stalls because humans are trying to do hard work inside a system that is overloaded, sil

Enabling Clinical Trial Technology that Cuts Risk and Speeds Patient Access

Send us Fan Mail Clinical trials are meant to generate evidence, not paperwork, but too many studies still depend on spreadsheets, duplicate data entry and unconnected s

The Emperor’s Naked And The Trial’s Still On w/ Dr. Grant Coren

Send us Fan Mail “Patients first” sounds simple until you follow the incentives. We’re joined by Dr Grant Coren, a genetics-trained PhD who moved from cancer research i

What If The Real Blocker Is Coordination Not Data w/ Anastasia Christianson

Send us Fan Mail AI is everywhere in pharma right now, yet drug development still feels slow, fragmented, and full of avoidable rework. We sit down with Anastasia Christ

Electrifying the Factory: Agentic AI For Faster Clinical Trials with Pamela Tenaerts

Send us Fan Mail The clinical trial system is starting to look like a motorway at a standstill: more and more drugs are lining up, but the lanes ahead are already full.

Why Big Pharma Feels Like A Financial Institution & Don't Pee on Medical Gloves with Anish Shindore

Send us Fan Mail A medicine can be proven safe and effective, approved by regulators, and still fail the one test that matters: actually reaching patients in the real wo

How Biotech Ideas Become Real Patient Impact w/ new co-hosts Alex and Dimitri

Send us Fan Mail This is the first episode in the rebranded show! Drug and medical device breakthroughs do not reach patients because they’re clever in a lab. They reac

Dear Pharma, Your Patient Isn’t A KPI with Mark Duman

Send us Fan Mail What happens when we stop calling people “subjects” and start inviting them to help build the solutions they need? We sit down with pharmacist and patie

Audit Trails, RBQM, And Agentic AI Explained

Send us Fan Mail Ever wondered why a clean CSR still leaves you unsure how a trial actually ran? We dive into the hidden layer that explains the “how”: audit trails acro

Why Bringing The Trial To The Patient Beats Dragging Patients To Sites

Send us Fan Mail Want clinical research that respects real life? We sit down with Caroline Potts, GM of Site and Patient Services at MRN, to rethink how patients are rec

Inside Sionna’s Bid To Normalize CFTR Function

Send us Fan Mail Two leaders from Sionna Therapeutics walk through a 15‑year journey from Genzyme science to a public company advancing NBD1‑targeted therapies in cystic

AI Won’t Replace Writers, But Writers Who Use AI Will Outpace The Rest with Bilal Bham

Send us Fan Mail What if the documents behind a clinical trial were written with the patient’s voice in mind and delivered at the speed modern science deserves? We sit d

From Grief To Global Advocacy For Clinical Research In Infectious Diseases with Christian John Lillis

Send us Fan Mail A routine dental visit, a few days of diarrhea, and then the unthinkable: septic shock and a life lost within 24 hours. Our guest, Christian John Lillis

Decoding Real-World Evidence: Beyond Clinical Trials with Manfred Stapff

Send us Fan Mail What if millions of electronic health records could transform how we understand medicine? In this thought-provoking conversation with Dr. Manfred Stapff

Democratizing Drug Development Through AI-Native Platforms with Ilya Burkov

Send us Fan Mail Cloud computing is transforming biotech by offering purpose-built infrastructure that supports AI-driven drug discovery and development while meeting st

Incorruptible Evidence: Blockchain's Promise for Faster Drug Approvals w. Dominik Lysek

Send us Fan Mail Dominik Lysek, CEO of PharmaTrail, explains how blockchain technology can solve trust issues in clinical trials by providing an incorruptible audit trai

Revolutionizing Dentistry: AI and Research Innovation with Dr. Shervin Molayem

Send us Fan Mail Dr. Shervin Molayem shares his journey of innovation in dentistry, starting with his discovery of a connection between periodontal disease and COVID-19

How early diagnostics of lung cancer can lead to better survival rates with Chris Wood

Send us Fan Mail Chris Wood discusses how early diagnostics of lung cancer through artificial intelligence and medical imaging can lead to better survival rates through

From Hopeless to High-Performing: Transforming Pharma Teams with Rajesh Anandan and Nechama Katan

Send us Fan Mail Building high-performing teams in life sciences requires understanding how neurodiversity can be an advantage and designing work systems that enable dif

Data Governance in the Age of Generative AI with Sebastian Andruszczak

Send us Fan Mail Sebastian Andruszczak, Chief Growth Officer at Holisticon (part of the Nexer Group), brings fresh perspective to the conversation around generative AI a